Truist Securities Maintains Buy on Amrize, Lowers Price Target to $65

Benzinga Newsdesk www.benzinga.com Neutral 49.6%

Neg 0% Neu 49.6% Pos 0%

Truist Securities analyst Keith Hughes maintains Amrize (NYSE:AMRZ) with a Buy and lowers the price target from $75 to $65.